← Back to Search

STP705 for Abdominal Obesity

Phase 1
Waitlist Available
Led By Mark Nestor, MD
Research Sponsored by Sirnaomics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

Study Summary

This trial is testing how well different doses of a new medication work, compared to a fake medication (vehicle), in people who do not know if they are taking the real medication or the fake one.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence (severity and causality) of any AEs
Number of subjects with presence and severity of the following Local Skin Reactions (LSR): erythema, edema, bruising.
Number of subjects with presence and severity of the following Local Skin Reactions (LSR): pain and stinging/burning.

Trial Design

7Treatment groups
Experimental Treatment
Placebo Group
Group I: STP705, 320ug/mL, 1.0 ccExperimental Treatment1 Intervention
Volume of Injection 1.0cc
Group II: STP705, 320ug/mL, 0.5 ccExperimental Treatment1 Intervention
Volume of Injection 0.5cc
Group III: STP705, 240ug/mL, 1.0 ccExperimental Treatment1 Intervention
Volume of Injection 1.0cc
Group IV: STP705, 240 ug/mL, 0.5 ccExperimental Treatment1 Intervention
Volume of Injection 0.5cc
Group V: STP705, 120ug/mL, 1.0 ccExperimental Treatment1 Intervention
Volume of Injection 1.0cc
Group VI: STP705, 120ug/mL, 0.5 ccExperimental Treatment1 Intervention
Volume of Injection 0.5cc
Group VII: VehiclePlacebo Group1 Intervention
1.0cc placebo
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
STP705
2022
Completed Phase 2
~180

Find a Location

Who is running the clinical trial?

SirnaomicsLead Sponsor
11 Previous Clinical Trials
329 Total Patients Enrolled
Mark Nestor, MDPrincipal InvestigatorCenter for Clinical and Cosmetic Research
3 Previous Clinical Trials
82 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are patients still invited to join this clinical investigation?

"Based on the clinicaltrials.gov website, this research endeavour is actively enrolling subjects as of October 24th 2022. The initial listing was posted to the site on August 1st 2020."

Answered by AI

Has STP705 received the green light from the Food and Drug Administration?

"Our team at Power assessed STP705's safety to be a 1, as this is an exploratory Phase 1 trial with limited evidence in regards to its efficacy and security."

Answered by AI

What is the cap on enrollees for this investigation?

"Affirmative. Clinicaltrials.gov has the most up-to-date information that shows this clinical trial began recruiting on August 1st 2022 and is still active, with 10 patients needed from 2 locations."

Answered by AI

What prerequisites must be met for a person to qualify for this clinical investigation?

"This experimental trial is seeking 10 adult participants aged 18 to 65 with obesity and visceral fat accumulation. Aspiring patients must also be male or non-pregnant female, provide written consent, postmenopausal/surgically sterile/use birth control, have a negative urine pregnancy test at the start of screening and baseline visits as well as agree to an abdominoplasty procedure prior to enrolment in order to qualify for the study."

Answered by AI

Is this research endeavor open to individuals who have reached their golden years?

"As per the eligibility parameters laid out for this study, applicants must be 18 years or older and no more than 65."

Answered by AI

Who else is applying?

What state do they live in?
Ohio
How old are they?
65+
What site did they apply to?
Center for Clinical and Cosmetic Research
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
A Study to Evaluate Safety, Tolerability of Subcutaneous Injection in Adult Subjects Undergoing Abdominoplasty
2022. "A Study to Evaluate Safety, Tolerability of Subcutaneous Injection in Adult Subjects Undergoing Abdominoplasty". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05422378.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top